Valsabel Tablets 40 mg (Valsartan)

Adult dose

Essential hypertension: It is recommended to take 80 mg orally once a day. If blood pressure is not well controlled, the dose may be increased to 160 mg once daily, and up to a maximum of 320 mg. Elderly patients (aged 75 years and older) should start with 40 mg once a day. Patients with renal impairment: For those with creatinine clearance of 10 to 20 mL/min, it is recommended to begin treatment with 40 mg once daily. For creatinine clearance

Child dose

The safety and efficacy of this medication in children and adolescents under 18 years of age have not been established.

This medication can cause serious harm to the fetus and newborn, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. It should not be used by patients with severe liver dysfunction, cirrhosis, or biliary obstruction. Additionally, patients with hereditary angioedema or a history of angioedema while receiving ACE inhibitors or angiotensin II receptor antagonists should not use this medication. Patients with severe renal impairment are also advised against using this drug. In diabetic patients with moderate to severe renal impairment, it should not be used in combination with certain medications. The elderly, patients with hyperkalemia, and those with mild to moderate liver impairment should use this medication cautiously, and dosage adjustment may be necessary. Patients with heart valve disease or cardiovascular disease, patients with fluid depletion, and patients with renal artery stenosis also require caution. Patients with heart failure or post-myocardial infarction should have their renal function periodically assessed before and during treatment, as changes in renal function may occur. Blood pressure may drop rapidly, so dosing should be started at a low level and gradually increased while closely monitoring the patient's condition. This medication may increase serum potassium levels, so patients with hyperkalemia should avoid or use it with caution, and potassium levels should be frequently monitored when taken with potassium-sparing diuretics or potassium supplements. Interactions may occur when used in combination with other antihypertensive medications or multiple drugs, so it must be taken as directed by a physician. Symptoms such as dizziness or drowsiness may occur, necessitating caution when driving or operating machinery. The safety and efficacy of this medication in children and adolescents have not been established, thus it is advisable for those under 18 not to use it. In case of overdose, symptoms such as hypotension or decreased consciousness may appear, requiring immediate medical attention for appropriate treatment. This medication should be kept out of the reach of children and should not be transferred to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory distress associated with cough and fever, jaundice (skin or eyes turning yellow), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination issues

Mild side effects

• Headache
• dizziness
• viral infection
• upper respiratory infection
• cough
• diarrhea
• fatigue
• rhinitis
• sinusitis
• back pain

This medication should be stored in a tightly closed container to prevent air and moisture from entering, and it should be kept in a cool place below 30 degrees centigrade, avoiding high temperatures and humidity. This will help maintain the effectiveness of the medication over time.

Appearance

Yellow oval-shaped film-coated tablets

Package unit

28 tablets (14 tablets per PTP × 2)